Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-10-01 4:35 pm Unchanged | 2026-09-29 | 13D | KARDIGAN INC KARD | Perceptive Advisors LLC | 8,254,144 8.800% | 0 (Unchanged) | Filing History |
| 2026-09-23 4:30 pm Purchase | 2026-09-16 | 13G | NURIX THERAPEUTICS INC NRIX | Perceptive Advisors LLC | 5,536,629 5.300% | 5,536,629 (New Position) | Filing History |
| 2026-08-27 4:00 pm Purchase | 2026-08-26 | 13D | IMMATICS N V IMTX | Perceptive Advisors LLC | 11,418,016 7.600% | 1,948,311 (+20.57%) | Filing History |
| 2026-08-25 4:00 pm Purchase | 2026-08-22 | 13D | LEONABIO INC LONA | Perceptive Advisors LLC | 1,889,403 19.990% | 7,033 (+0.37%) | Filing History |
| 2026-08-14 5:22 pm Purchase | 2026-06-30 | 13D | SOLID BIOSCIENCES INC SLDB | Perceptive Advisors LLC | 12,046,579 11.200% | 77,500 (+0.65%) | Filing History |
| 2026-08-14 5:22 pm Unchanged | 2026-06-30 | 13G | SPYRE THERAPEUTICS, INC SYRE | Perceptive Advisors LLC | 4,319,496 4.900% | 0 (Unchanged) | Filing History |
| 2026-08-14 5:21 pm Purchase | 2026-06-30 | 13G | X4 PHARMACEUTICALS INC XFOR | Perceptive Advisors LLC | 8,085,006 8.100% | 1,195,843 (+17.36%) | Filing History |
| 2026-08-14 5:21 pm Purchase | 2026-06-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | Perceptive Advisors LLC | 1,700,000 4.500% | 252,218 (+17.42%) | Filing History |
| 2026-08-14 5:21 pm Purchase | 2026-06-30 | 13G | SUTRO BIOPHARMA INC STRO | Perceptive Advisors LLC | 1,304,846 7.900% | 406,821 (+45.30%) | Filing History |
| 2026-08-14 5:20 pm Purchase | 2026-06-30 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Perceptive Advisors LLC | 6,627,501 7.300% | 195,758 (+3.04%) | Filing History |
| 2026-08-14 5:20 pm Sale | 2026-06-30 | 13G | ENVVENO MED CORP COM NVNO | Perceptive Advisors LLC | 24,605 3.500% | -43,920 (-64.09%) | Filing History |
| 2026-08-14 5:20 pm Sale | 2026-06-30 | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | Perceptive Advisors LLC | 11,634,211 9.100% | -1,180,902 (-9.21%) | Filing History |
| 2026-08-14 5:20 pm Sale | 2026-06-30 | 13G | INVIVYD, INC. IVVD | Perceptive Advisors LLC | 18,490,636 6.300% | -3,294,530 (-15.12%) | Filing History |
| 2026-08-14 5:19 pm Purchase | 2026-06-30 | 13G | OPUS GENETICS, INC. IRD | Perceptive Advisors LLC | 9,233,710 9.990% | 403,565 (+4.57%) | Filing History |
| 2026-08-14 5:19 pm Purchase | 2026-06-30 | 13G | INHIBRX BIOSCIENCES INC INBX | Perceptive Advisors LLC | 1,489,443 9.990% | 28,338 (+1.94%) | Filing History |
| 2026-08-14 5:19 pm Sale | 2026-06-30 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Perceptive Advisors LLC | 10,320,875 6.900% | -2,315,000 (-18.32%) | Filing History |
| 2026-08-14 5:19 pm Purchase | 2026-06-30 | 13G | ENGENE HLDGS INC ENGN | Perceptive Advisors LLC | 6,899,803 9.990% | 129,198 (+1.91%) | Filing History |
| 2026-08-14 5:18 pm Purchase | 2026-08-07 | 13G | BLOSSOMHILL THERAPEUTICS INC C BLSM | Perceptive Advisors LLC | 1,808,533 5.900% | 1,808,533 (New Position) | Filing History |
| 2026-08-14 5:18 pm Purchase | 2026-06-30 | 13G | ALTO NEUROSCIENCE INC ANRO | Perceptive Advisors LLC | 4,176,711 9.990% | 926,777 (+28.52%) | Filing History |
| 2026-08-10 4:00 pm Purchase | 2026-06-30 | 13G | RELAY THERAPEUTICS INC RLAY | Perceptive Advisors LLC | 14,106,187 6.400% | 13,667,716 (+3117.13%) | Filing History |